Overall, our results indicate that there is an interaction between MAP4K4 and ACSL4 that mediates radioresistance in breast cancer cells, with MAP4K4 acting as an upstream effector of ACSL4. This evidence concerns the gene MAP4K4 and breast carcinoma.